PHASE II STUDY OF IFOSFAMIDE, CARBOPLATIN, AND ETOPOSIDE IN PATIENTS WITH A FIRST RECURRENCE OF GLIOBLASTOMA MULTIFORME

被引：0
|
作者：
Aoki, T. [1 ]
Ueba, T. [3 ]
Takahashi, J. [1 ]
Miyatake, S. [2 ]
Nozaki, K. [4 ]
Taki, W. [5 ]
Matsutani, M. [6 ]
机构：
[1] Kitano Hosp, Brain Tumor Ctr, Osaka, Japan
[2] Osaka Med Coll, Takatsuki, Osaka 569, Japan
[3] Kishiwada City Hosp, Kishiwada, Japan
[4] Shiga Univ Med Sci, Otsu, Shiga 52021, Japan
[5] Mie Univ, Tsu, Mie 514, Japan
[6] Saitama Med Univ, Int Med Ctr, Saitama, Japan
来源：
NEURO-ONCOLOGY | 2010年 / 12卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：48 / 48
页数：1
相关论文
共 50 条
  • [21] TREATMENT OF RECURRENT SUPRATENTORIAL GLIOMAS WITH THE ASSOCIATION OF IFOSFAMIDE, CARBOPLATIN AND ETOPOSIDE - A PHASE-II STUDY
    AMERI, A
    SANSON, M
    MONJOUR, A
    RONCHIN, P
    POISSON, M
    DELATTRE, JY
    NEUROLOGY, 1995, 45 (04) : A263 - A263
  • [22] Phase II study of temozolamide in patients with glioblastoma multiforme
    Janinis, J
    Tsantila, A
    Samantas, E
    Aravantinos, G
    Sitaras, N
    Skarlos, D
    ANNALS OF ONCOLOGY, 1998, 9 : 181 - 181
  • [23] Carboplatin and etoposide combined with bevacizumab for the treatment of recurrent glioblastoma multiforme
    Francesconi, Alessandra B.
    Dupre, Simon
    Matos, Marco
    Martin, David
    Hughes, Brett G.
    Wyld, David K.
    Lickliter, Jason D.
    JOURNAL OF CLINICAL NEUROSCIENCE, 2010, 17 (08) : 970 - 974
  • [24] A phase II study of temozolomide vs. procarbazine in patients with glioblastoma multiforme at first relapse
    Yung, WKA
    Albright, RE
    Olson, J
    Fredericks, R
    Fink, K
    Prados, MD
    Brada, M
    Spence, A
    Hohl, RJ
    Shapiro, W
    Glantz, M
    Greenberg, H
    Selker, RG
    Vick, NA
    Rampling, R
    Friedman, H
    Phillips, P
    Bruner, J
    Yue, N
    Osoba, D
    Zaknoen, S
    Levin, VA
    BRITISH JOURNAL OF CANCER, 2000, 83 (05) : 588 - 593
  • [25] A phase II study of temozolomide vs. procarbazine in patients with glioblastoma multiforme at first relapse
    W K A Yung
    R E Albright
    J Olson
    R Fredericks
    K Fink
    M D Prados
    M Brada
    A Spence
    R J Hohl
    W Shapiro
    M Glantz
    H Greenberg
    R G Selker
    N A Vick
    R Rampling
    H Friedman
    P Phillips
    J Bruner
    N Yue
    D Osoba
    S Zaknoen
    V A Levin
    British Journal of Cancer, 2000, 83 : 588 - 593
  • [26] Multicenter phase II trial of temozolomide in patients with glioblastoma multiforme at first relapse
    Brada, M
    Hoang-Xuan, K
    Rampling, R
    Dietrich, PY
    Dirix, LY
    Macdonald, D
    Heimans, JJ
    Zonnenberg, BA
    Bravo-Marques, JM
    Henriksson, R
    Stupp, R
    Yue, N
    Bruner, J
    Dugan, M
    Rao, S
    Zaknoen, S
    ANNALS OF ONCOLOGY, 2001, 12 (02) : 259 - 266
  • [27] PHASE II STUDY OF BEVACIZUMAB AND ERLOTINIB IN PATIENTS WITH RECURRENT GLIOBLASTOMA MULTIFORME
    Reardon, David A.
    Sathornsumetee, Sith
    Vredenburgh, James J.
    Rich, Jeremy N.
    Desjardins, Annick
    Quinn, Jennifer A.
    Mathe, Alyssa
    Gururangan, Sridharan
    Friedman, Allen H.
    Friedman, Henry S.
    NEURO-ONCOLOGY, 2009, 11 (02) : 231 - 231
  • [28] Phase II study of bevacizumab and erlotinib in patients with recurrent glioblastoma multiforme
    Sathornsumetee, S.
    Vredenburgh, J. J.
    Rich, J. N.
    Desjardins, A.
    Quinn, J. A.
    Mathe, A. E.
    Gururangan, S.
    Friedman, A. H.
    Friedman, H. S.
    Reardon, D. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [29] Ifosfamide, carboplatin, etoposide with or without bortezomib in patients with relapsed/refractory Hodgkin lymphoma: results of a randomized phase II trial
    Karuturi, Meghan
    Younes, Anas
    Fayad, Luis
    Kwak, Larry
    Pro, Barbara
    Shah, Jatin
    Oki, Yasuhiro
    Simien, Rinata
    Liboon, Mary Joy
    Hutto, Toni
    Feng, Lei
    Horowitz, Sandra
    Nieto, Yago
    Anderlini, Paolo
    Alousi, Amin
    Popat, Uday
    Medeiros, L. Jeffrey
    Miranda, Roberto
    Fanale, Michelle
    LEUKEMIA & LYMPHOMA, 2016, 57 (02) : 445 - 447
  • [30] PHASE II STUDY OF PEMBROLIZUMAB PLUS SURVAXM FOR GLIOBLASTOMA AT FIRST RECURRENCE
    Ahluwalia, Manmeet
    Peereboom, David
    Rauf, Yasmeen
    Schilero, Cathy
    Ciolfi, Marci
    Ciesielski, Michael
    Fenstermaker, Robert
    NEURO-ONCOLOGY, 2020, 22 : 34 - 35
12345